newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes

NEW YORK, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene...